EN, B., P, N., FO, G., X, R., T, X., S, A., . . . M, A. (2023). Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. Research square. https://doi.org/10.21203/rs.3.rs-3161761/v1
Chicago Style (17th ed.) CitationEN, Baruch, et al. "Inflammation Induced by Tumor-associated Nerves Promotes Resistance to Anti-PD-1 Therapy in Cancer Patients and Is Targetable by Interleukin-6 Blockade." Research Square 2023. https://doi.org/10.21203/rs.3.rs-3161761/v1.
MLA (9th ed.) CitationEN, Baruch, et al. "Inflammation Induced by Tumor-associated Nerves Promotes Resistance to Anti-PD-1 Therapy in Cancer Patients and Is Targetable by Interleukin-6 Blockade." Research Square, 2023, https://doi.org/10.21203/rs.3.rs-3161761/v1.